Both in Pharmaceuticals
Nkarta vs Anixa Biosciences
Over the past year NKTX returned −24.6% and ANIX returned −24.6%; their daily moves had a correlation of 0.22.
NKTX −24.6% ANIX −24.6%Growth of $1, one year, split-adjusted
| Metric | NKTX | ANIX |
|---|---|---|
| Price | $1.56 | $3.12 |
| Market cap | $111.7M | $108.5M |
| Today | −6.02% | −5.45% |
| 1 month | −39.1% | +12.6% |
| 6 months | −46.8% | −0.6% |
| Year to date | −15.7% | 0.0% |
| 1 year | −25.4% | −25.0% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $182.8M | $13.9M |
| Dividend yield | — | — |
| Volatility (60d) | 62.3% | 58.9% |
| Short % of float | 8.1% | 7.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).